Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ.

Int J Neuropsychopharmacol. 2017 Feb 1;20(2):121-179. doi: 10.1093/ijnp/pyw100.

2.

Endoxifen, a New Treatment Option for Mania: A Double-Blind, Active-Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen.

Ahmad A, Sheikh S, Shah T, Reddy MS, Prasad B, Verma KK, Chandrakant BB, Paithankar M, Kale P, Solanki RV, Patel R, Barkate H, Ahmad I.

Clin Transl Sci. 2016 Jun 27. doi: 10.1111/cts.12407. [Epub ahead of print] Erratum in: Clin Transl Sci. 2017 Mar;10 (2):117.

3.

Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study.

Bourin MS, Severus E, Schronen JP, Gass P, Szamosi J, Eriksson H, Chandrashekar H.

Int J Bipolar Disord. 2014 Nov 8;2:14. doi: 10.1186/s40345-014-0014-9. eCollection 2014.

4.

Bipolar depression: clinically missed, pharmacologically mismanaged.

Lloyd LC, Giaroli G, Taylor D, Tracy DK.

Ther Adv Psychopharmacol. 2011 Oct;1(5):153-62. doi: 10.1177/2045125311420752.

5.

Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders.

Zhang L, Wang G, Luo J, Zhang QE, Zhao Q, Deng QY, Ma X.

Neuropsychiatr Dis Treat. 2013;9:575-80. doi: 10.2147/NDT.S42473. Epub 2013 Apr 26.

6.

How assess drugs in the treatment of acute bipolar mania?

Bourin M, Thibaut F.

Front Pharmacol. 2013 Jan 29;4:4. doi: 10.3389/fphar.2013.00004. eCollection 2013.

7.

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

Fountoulakis KN, Gonda X, Vieta E, Rihmer Z.

Ann Gen Psychiatry. 2011 Mar 24;10(1):8. doi: 10.1186/1744-859X-10-8.

8.

Antipsychotic effects of quetiapine in naturalistic long term follow up study.

Lee JS, Ahn JH, Kim DH, Kim JJ, Kim TY, Yoo SY, Lee DG, Lee SH, Lim SW, Lim WJ, Jung IK, Jung HK, Cho DH, Cho IH, Kim CY.

Psychiatry Investig. 2010 Jun;7(2):128-34. doi: 10.4306/pi.2010.7.2.128. Epub 2010 May 4.

9.

Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.

Lydiard RB, Culpepper L, Schiöler H, Gustafsson U, Paulsson B.

Prim Care Companion J Clin Psychiatry. 2009;11(5):215-25. doi: 10.4088/PCC.08m00659.

10.
11.

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.

Mundo E, Cattaneo E, Zanoni S, Altamura AC.

Neuropsychiatr Dis Treat. 2006 Jun;2(2):139-48.

12.

Quetiapine in the treatment of schizophrenia and related disorders.

Riedel M, Müller N, Strassnig M, Spellmann I, Severus E, Möller HJ.

Neuropsychiatr Dis Treat. 2007 Apr;3(2):219-35.

13.

Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder.

Nassir Ghaemi S, Shirzadi AA, Filkowski M.

Medscape J Med. 2008;10(9):211. Epub 2008 Sep 10.

15.

Acute and long-term treatment of mania.

Vieta E, Sanchez-Moreno J.

Dialogues Clin Neurosci. 2008;10(2):165-79. Review.

16.

Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

Fountoulakis KN, Vieta E, Siamouli M, Valenti M, Magiria S, Oral T, Fresno D, Giannakopoulos P, Kaprinis GS.

Ann Gen Psychiatry. 2007 Oct 9;6:27.

17.

Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes.

Hardoy MC, Garofalo A, Mellino G, Tuligi F, Cadeddu M, Carta MG.

Clin Pract Epidemiol Ment Health. 2007 Sep 24;3:17.

18.

The psychopathology and treatment of bipolar disorder.

Miklowitz DJ, Johnson SL.

Annu Rev Clin Psychol. 2006;2:199-235. Review.

19.
20.

Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy.

Kim DJ, Lyoo IK, Yoon SJ, Choi T, Lee B, Kim JE, Lee JS, Renshaw PF.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1182-8. Epub 2007 Apr 24.

Supplemental Content

Support Center